Snowball logo
logo
1801

Innovent Biologics Inc

HK$99.35-HK$3.05Β  (2.98%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
4,269.74,556.45,643.28,853.413,041.521,859.6
COGS
5739311,6431,419.13,043.85,331.8
Gross Profit
3,696.73,625.44,000.37,434.39,997.716,527.8
Operating Expenses & Income
Operating Income
(2,988.6)(3,122.8)(1,527)(710.3)733.629.98
Total Operating Expenses
6,663.36,207.35,527.37,191.89,264.116,529.3
R&D Expenses
2,478.12,871.22,025.52,519.32,624.25,131
Selling General & Admin Expenses
3,612.2835.5682.2693.59271,617.6
Earnings from Continuing Operations
Interest Expense
(62.46)(101.7)(89.68)(63.57)(77.54)(330.9)
Interest Income
62.46101.789.68102.1176.4278.1
Income Tax Expense
87.048.801(105.9)15.0425.3640.4
Net Income
Net Income
(3,138.1)(2,179.3)(934.7)(88.92)813.6728.2
Supplemental
EBIT
(2,988.6)(2,068.8)(950.9)(710.3)733.627.23
EBITDA
(2,374.5)(1,749.3)(600.8)(451.3)1,310.2861.1
In millions of HKD, except % and values per 1 share